Table 3.
Comparison of blood routine indices between different treatments in COVID-19 convalescents
| Indices (unit) | Reference range | Non-treatment (n = 425) | TCM treatment (n = 143) | P value |
|---|---|---|---|---|
| Platelet system | ||||
| PLT (109/L) | 125-350 | 191.36±105.01 | 238.62±56.99***↑ | 0.0000 |
| PCT2 (%) | 0.18-0.39 | 0.21±0.10 | 0.25±0.05***↑ | 0.0000 |
| MPV (fL) | 6.5-12 | 10.92±1.10 | 10.72±0.94 | 0.0590 |
| P-LCR (%) | 17.5-42.3 | 32.07±8.65 | 30.60±7.70 | 0.0747 |
| PDW | 15-17 | 12.88±2.72 | 12.73±2.16 | 0.5506 |
| Erythrocyte system | ||||
| RBC (1012/L) | 3.8-5.1 | 4.47±0.58 | 4.66±0.45***↑ | 0.0003 |
| MCV (fL) | 82-100 | 93.04±5.75 | 91.78±3.88*↓ | 0.0145 |
| RDW-SD (fL) | 38.2-49.2 | 45.58±6.82 | 43.84±4.21**↓ | 0.0042 |
| RDW-CV (%) | 12.1-14.3 | 13. 41±1.56 | 13.04±1.12**↓ | 0.0089 |
| HCT (%) | 35-45 | 41.36±4.28 | 42.70±3.57**↑ | 0.0008 |
| Hemoglobin parameter | ||||
| HGB (g/L) | 115-150 | 132.97±15.77 | 139.64±14.41***↑ | 0.0000 |
| MCH (pg) | 27-34 | 29.86±1.80 | 29.97±1.62 | 0.5112 |
| MCHC (g/L) | 316-354 | 321.20±12.93 | 326.58±10.27***↑ | 0.0000 |
Continuous variables were analyzed using one-way ANOVA (Tamhane's T2) test. *P<0.05, **P<0.01, ***P<0.001 vs non-treatment group. The symbols ↓ and ↑ represented significantly higher or lower.